SynergAsia Health has completed and are currently conducting several vascular clinical trials relating to novel interventional devices treating Peripheral Arterial Diseases (SFA, BTK), AVF and AVG. Such trials ranges from First-in-man to Double Blind Randomised Control trials.
All completed trials were completed in timely manner with excellent results presented in major meetings and manuscript submitted.